Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)


The ketogenic diet (KD) is an established, effective, nonpharmacologic treatment for children with pharmacoresistant epilepsy. Although the KD is the most well-established dietary therapy for epilepsy, it is too restrictive and is associated with serious complications; therefore, alternative lower-fat diets, including a modified Atkins diet and low-glycemic index diet, have been developed. Recent ongoing clinical evidence suggests that other dietary therapies have an efficacy almost comparable to that of the KD. In addition, a diet rich in polyunsaturated fatty acids appears to increase the efficacy of diet therapy and reduce the complications of a high-fat diet. Here, we review the systematic information about lower-fat diets and better-quality dietary therapies and the current clinical status of each of these dietary approaches.

Original languageEnglish
Pages (from-to)327-331
Number of pages5
JournalKorean Journal of Pediatrics
Issue number8
Publication statusPublished - 2013 Aug

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Pediatrics


Dive into the research topics of 'Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy'. Together they form a unique fingerprint.

Cite this